Boxer Capital Founded 2005
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 62
Average round size
info
The average size of a deal this fund participated in
$90M
Portfolio companies 48
Rounds per year 3.00
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.13
Exits 28
Areas of investment
Biotechnology
Enterprise
Health Care
Industrial
Lifestyle
Summary

The leading representative office of defined VC is situated in the Windermere. The company was established in North America in United States.

The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight AveXis, Passage Bio, Codiak Biosciences. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical, Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Comparing to the other companies, this Boxer Capital performs on 21 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 8-9 participants. Despite the Boxer Capital, startups are often financed by OrbiMed, Vivo Capital, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, Alexandria Venture Investments, Vivo Capital. In the next rounds fund is usually obtained by RA Capital Management, Tavistock Life Sciences, Surveyor Capital.

We also calculated 3 valuable employees in our database.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Nuvalent
Biotechnology
Life Science
Therapeutics
Early Stage Venture
135M11 May 2021 United States, Cambridge
Early Stage Venture
105M28 Apr 2021
Early Stage Venture
100M13 Apr 2021
Early Stage Venture
125M12 Apr 2021
Asher Bio
Biotechnology
Therapeutics
Early Stage Venture
55M23 Mar 2021 United States, San Francisco
Vividion Therapeutics
Biotechnology
Health Care
Therapeutics
Late Stage Venture
135M24 Feb 2021 United States, San Diego
Nuvation Bio
Biotechnology
Pharmaceutical
Post-IPO Equity
502M11 Feb 2021 United States, New York
Day One Biopharmaceuticals
Biopharma
Biotechnology
Health Care
Pharmaceutical
Early Stage Venture
130M10 Feb 2021 United States, South San Francisco
Gemini Therapeutics
Biopharma
Biotechnology
Health Diagnostics
95M08 Feb 2021 United States, Cambridge
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Boxer Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: